Left Atrial and Left Atrial Appendage 4D Blood Flow Dynamics in Atrial Fibrillation

Background—Atrial 4D flow magnetic resonance imaging was used for the characterization of left atrial (LA) and left atrial appendage (LAA) flow dynamics in patients with atrial fibrillation (AF). Methods and Results—4D flow magnetic resonance imaging measured in vivo 3D blood flow velocities in 60 AF patients and 15 controls. Anatomic maps of LA and LAA stasis and velocity were calculated to quantify atrial peak velocity, mean velocity, and stasis (velocities <0.1 m/s). In a substudy with 30 AF patients, 4D flow metrics were compared with Doppler transesophageal echocardiography. For all 15 controls, LAA mean and peak velocities were consistently lower (by 21%/12%; P<0.001) while LAA stasis was higher (by 58%; P<0.001) compared with the LA. In contrast, lower LAA velocity and increased LAA stasis were only found in a fraction (38 of 60) of AF patients. In AF patients, increased CHA2DS2-VASc score was associated with significantly (P<0.043) reduced LA velocities and elevated stasis. There was a heterogeneous expression of atrial flow dynamics, and 25% to 68% of AF patients demonstrated flow in the normal range: 25%/68% for LA/LAA stasis and 38%/60% for LA/LAA peak velocities. Transesophageal echocardiography velocities modestly but significantly (P<0.05) correlated with 4D flow–based LA velocities (r=0.41) and stasis (r=−0.39). Conclusions—AF resulted in overall impaired but individually variable flow dynamics in both the LA and LAA. AF patients demonstrated atrial flow in the normal range, despite elevated CHA2DS2-VASc score.

[1]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[2]  Conti Cr ATRIAL FIBRILLATION, TRANSESOPHAGEAL ECHO, ELECTRICAL CARDIOVERSION, AND ANTICOAGULATION , 1994 .

[3]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[4]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[5]  A. Camm,et al.  Left atrial appendage: structure, function, and role in thromboembolism , 1999, Heart.

[6]  Velocity Quantification by Electrocardiography-Gated Phase Contrast Magnetic Resonance Imaging in Patients With Cardiac Arrhythmia: A Simulation Study Based on Real Time Transesophageal Echocardiography Data in Atrial Fibrillation , 2015, Journal of computer assisted tomography.

[7]  P. Walker,et al.  Semiautomated method for noise reduction and background phase error correction in MR phase velocity data , 1993, Journal of magnetic resonance imaging : JMRI.

[8]  Daniel C. Lee,et al.  Three-dimensional left atrial blood flow characteristics in patients with atrial fibrillation assessed by 4D flow CMR. , 2016, European heart journal cardiovascular Imaging.

[9]  Michael Markl,et al.  Left atrial flow velocity distribution and flow coherence using four‐dimensional FLOW MRI: A pilot study investigating the impact of age and Pre‐ and Postintervention atrial fibrillation on atrial hemodynamics , 2013, Journal of magnetic resonance imaging : JMRI.

[10]  D. Lane,et al.  A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice , 2011, Journal of thrombosis and haemostasis : JTH.

[11]  Michael Markl,et al.  4D flow MRI , 2012, Journal of magnetic resonance imaging : JMRI.

[12]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[13]  Michael Markl,et al.  Left Atrial 4-Dimensional Flow Magnetic Resonance Imaging: Stasis and Velocity Mapping in Patients With Atrial Fibrillation , 2016, Investigative radiology.

[14]  D. Singer,et al.  Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants , 2012, Stroke.

[15]  Mann Wj Atrial fibrillation, transesophageal echo, electrical cardioversion, and anticoagulation. , 1995 .

[16]  Sanghamitra Mohanty,et al.  Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. , 2012, Journal of the American College of Cardiology.

[17]  J. Halperin,et al.  Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  Michael Markl,et al.  Age, gender, blood pressure, and ventricular geometry influence normal 3D blood flow characteristics in the left heart. , 2013, European heart journal cardiovascular Imaging.

[19]  M. Olschewski,et al.  Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation--a transesophageal echocardiographic study in 500 patients with cerebral ischemia. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  Charles J Bruce,et al.  Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists , 2007, Anesthesia and Analgesia.

[21]  Silvia G Priori,et al.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.

[22]  Michael Markl,et al.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate , 2015, Circulation.

[23]  T Ebbers,et al.  Three dimensional flow in the human left atrium , 2001, Heart.

[24]  T Ebbers,et al.  Noninvasive measurement of time-varying three-dimensional relative pressure fields within the human heart. , 2002, Journal of biomechanical engineering.

[25]  M. Yacoub,et al.  Asymmetric redirection of flow through the heart , 2000, Nature.

[26]  M. Alley,et al.  Characteristics of intra-left atrial flow dynamics and factors affecting formation of the vortex flow – analysis with phase-resolved 3-dimensional cine phase contrast magnetic resonance imaging. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[27]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[28]  N J Pelc,et al.  Concomitant gradient terms in phase contrast MR: Analysis and correction , 1998, Magnetic resonance in medicine.

[29]  Jennifer G. Robinson,et al.  ACCF/AHA TASK FORCE MEMBERS , 2013 .

[30]  M. Aguilar,et al.  Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks , 2008 .

[31]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[32]  Jeroen J. Bax,et al.  Flow Assessment Through Four Heart Valves Simultaneously Using 3-Dimensional 3-Directional Velocity-Encoded Magnetic Resonance Imaging With Retrospective Valve Tracking in Healthy Volunteers and Patients With Valvular Regurgitation , 2009, Investigative radiology.

[33]  C. Pollick,et al.  Assessment of Left Atrial Appendage Function by Transesophageal Echocardiography: Implications for the Development of Thrombus , 1991, Circulation.

[34]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[35]  Leon Poller,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.